US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 4.689
  • -0.071-1.49%
Trading Mar 11 09:57 ET
212.02MMarket Cap-7.00P/E (TTM)

Y-mAbs Therapeutics Key Stats

Y-mAbs Therapeutics Q4 2024 Earnings Date

Currency:USDMar 4, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
26.70M
26.50M
-206.38K
Miss Est.
+14.29%
+13.41%
-0.77%
EPS
-0.12
-0.15
-0.03
Miss Est.
-485.93%
-650.00%
-28.64%
Strong Buy

Mar 11, 2025

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.758M--
--2025/Q1-- / 19.770M--
Mar 4, 20252024/Q426.495M / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.758M--
--2025/Q1-- / 19.770M--
Mar 4, 20252024/Q426.495M / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

Read more

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More